Katie has extensive experience advising on and litigating patents and supplementary protection certificates in the life sciences sector. She has worked on enforcement and validity disputes involving small-molecule pharmaceuticals, biologics and medical devices. Katie’s litigation work has seen her assisting clients on cases before the IPEC, High Court and Court of Appeal as well as the UPC.

Katie also assists clients with multi-jurisdictional litigation co-ordination projects, managing patent disputes across numerous territories and working closely with lawyers and patent attorneys throughout Europe, Asia and Latin America.

Katie is a key contributor to the annual review of patent cases which is published annually in the CIPA journal.

Examples of Katie’s work include:

• Accord v Novartis AG – Katie was part of a team of internationally recognised lawyers which represented Novartis in the defence of a DNI action instigated in the Central Division (Milan) by Accord in relation to a patent for Tasigna® (nilotinib).
• Dr Hill v Touchlight Genetics Limited (and others) – Acted for Touchlight in the successful defence of an entitlement challenge in the English Patents Court in relation to patents for in vitro synthesis of DNA.
• Lupin Healthcare Limited v Chiesi Farmaceutici SpA and Teva UK Limited v Chiesi Farmaceutici SpA – Acted for Chiesi in defence and enforcement of formulation and use patent rights relating to Foster, a respiratory medicine.
• Glaxo Group Ltd & Ors v Vectura Limited – Acted for Vectura in defence and enforcement of formulation patents relating to inhalable medicines.
• Teva UK Limited & another v Novartis Pharma AG & another – Acted for Novartis in relation to its patent for a second medical use. Leading in the coordination of this action with parallel actions in other European countries.
• Defending a revocation action brought against the paediatric extension to the SPC for imatinib (Teva v Novartis). Coordination of this defence with the parallel actions in other European countries.
• Acting for Smith & Nephew in disputes relating to their Durafiber and Durafiber Ag products.